Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Padoprazan - Ildong Pharmaceutical

Next Previous
Drug Profile

Padoprazan - Ildong Pharmaceutical

Alternative Names: DW-4421; ID-120040002

Latest Information Update: 05 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ildong Pharmaceutical
  • Developer Ildong Pharmaceutical; Yunovia
  • Class Amines; Antiulcers; Fluorobenzenes; Methyl ethers; Polyclonal antibodies; Pyridines; Pyrroles; Small molecules; Sulfones
  • Mechanism of Action Potassium-competitive acid blockers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Gastro-oesophageal reflux

Most Recent Events

  • 05 Feb 2026 Chemical structure information (Structure, Chemical name, molecular formula and CAS number) added.
  • 28 Jan 2026 Phase-III clinical trials in Gastro-oesophageal reflux (unspecified route), before January 2026 (Yunovia Pipeline, January 2026)
  • 23 Jan 2026 Daewon Pharmaceutical plans a phase I trial (In volunteers) in South Korea (NCT07364851) in March 2026

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top